company background image
600285 logo

Henan Lingrui Pharmaceutical SHSE:600285 Stock Report

Last Price

CN¥23.30

Market Cap

CN¥13.1b

7D

9.4%

1Y

45.1%

Updated

17 Apr, 2024

Data

Company Financials +

Henan Lingrui Pharmaceutical Co., Ltd.

SHSE:600285 Stock Report

Market Cap: CN¥13.1b

600285 Stock Overview

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China.

600285 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Henan Lingrui Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Henan Lingrui Pharmaceutical
Historical stock prices
Current Share PriceCN¥23.30
52 Week HighCN¥23.75
52 Week LowCN¥14.30
Beta0.33
1 Month Change11.22%
3 Month Change32.69%
1 Year Change45.08%
3 Year Change152.44%
5 Year Change162.39%
Change since IPO642.41%

Recent News & Updates

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Recent updates

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Shareholder Returns

600285CN PharmaceuticalsCN Market
7D9.4%-0.7%-0.2%
1Y45.1%-15.9%-17.8%

Return vs Industry: 600285 exceeded the CN Pharmaceuticals industry which returned -19% over the past year.

Return vs Market: 600285 exceeded the CN Market which returned -21.1% over the past year.

Price Volatility

Is 600285's price volatile compared to industry and market?
600285 volatility
600285 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement7.9%
Market Average Movement8.9%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 600285's share price has been volatile over the past 3 months.

Volatility Over Time: 600285's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19922,524Wei Xiongwww.lingrui.com

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others.

Henan Lingrui Pharmaceutical Co., Ltd. Fundamentals Summary

How do Henan Lingrui Pharmaceutical's earnings and revenue compare to its market cap?
600285 fundamental statistics
Market capCN¥13.14b
Earnings (TTM)CN¥526.17m
Revenue (TTM)CN¥3.23b

25.0x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600285 income statement (TTM)
RevenueCN¥3.23b
Cost of RevenueCN¥864.25m
Gross ProfitCN¥2.37b
Other ExpensesCN¥1.84b
EarningsCN¥526.17m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)0.93
Gross Margin73.26%
Net Profit Margin16.28%
Debt/Equity Ratio3.7%

How did 600285 perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

64%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.